NASDAQ:YMAT J-Star Q4 2025 Earnings Report $1.43 +0.15 (+11.72%) Closing price 04:00 PM EasternExtended Trading$1.57 +0.14 (+9.79%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast J-Star EPS ResultsActual EPS-$3.08Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AJ-Star Revenue ResultsActual Revenue($0.33) millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AJ-Star Announcement DetailsQuarterQ4 2025Date4/30/2026TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile J-Star Earnings HeadlinesJ-Star (NASDAQ:YMAT) Shares Down 4.3% - What's Next?September 23 at 2:21 AM | americanbankingnews.comYMAT - J-Star Holding Co., Ltd.September 16, 2026 | seekingalpha.comHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its valuation has doubled since the announcement, with some estimates putting the company's worth near 3 trillion dollars by IPO day. Google, Amazon, Nvidia and Microsoft have all taken stakes, while Goldman Sachs, Morgan Stanley and JPMorgan are competing for private shares. Anthropic's annualized revenue reportedly grew 80 times in the first quarter alone. See how investors are positioning ahead of this closely watched IPO.September 24 at 1:00 AM | Weiss Ratings (Ad)J-Star Holding Co., Ltd. (YMAT)September 9, 2026 | finance.yahoo.comJ-Star Holding Regains Nasdaq Compliance, Avoids Delisting RiskAugust 3, 2026 | tipranks.comJ-Star Holding Co. Regains Nasdaq Minimum Bid Price Compliance, Remains Listed on Nasdaq Capital MarketJuly 31, 2026 | quiverquant.comQSee More J-Star Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like J-Star? Sign up for Earnings360's daily newsletter to receive timely earnings updates on J-Star and other key companies, straight to your email. Email Address About J-StarJ-Star (NASDAQ:YMAT) Holding Co., Ltd. is a pharmaceutical research and development services company that supports pharmaceutical and biotechnology businesses throughout the drug-development process. Through its operating subsidiaries, the company provides contract development services designed to help clients advance drug candidates from early development through clinical manufacturing. J-Star’s services include preformulation studies, formulation development, analytical method development and validation, stability testing, and the production of clinical trial materials. Its work is intended to address the technical and manufacturing requirements associated with small-molecule pharmaceutical products. The company’s operations are associated with J-Star Research, a contract development organization serving pharmaceutical and biotechnology clients. Publicly available information about J-Star Holding’s corporate history, geographic reach and senior leadership is limited.View J-Star ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks3 Restaurant Stocks Near 52-Week Lows as Consumer Pressure BuildsPaychex Plunges, Providing the Entry Investors Have Been Waiting ForThe Case for Buying High-Yield General Mills Just StrengthenedEnergy Transfer Taps the AI Power BoomFull Throttle: Kratos and GE Fire Up a Next-Gen Defense EngineSandisk Joins the S&P 100—Is the Index Flow, or the AI Story, Driving the Stock? Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
